Profile for Russian Federation Patent: 2481110

US Patent Family Members and Approved Drugs for Russian Federation Patent: 2481110

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

US Patent Number	US Expiration Date	US Applicant	US Tradename	Generic Name
	Dec 23, 2028	Bayer Hlthcare	STAXYN	vardenafil hydrochloride

Patent RU2481110: Scope, Claims, and Landscape Analysis

Last updated: February 24, 2026

What are the core features and scope of RU2481110?

Patent RU2481110 is a pharmacological patent filed in Russia, primarily covering a specific formulation and method of treating a defined medical condition. Its claims focus on the composition's unique combination of active compounds and a novel method of administration.

Patent Classification and Filing Status

• Patent Classification: The patent falls under international classes A61K and A61P, associated with medicinal preparations and specific therapeutic methods.
• Filing Date and Priority: Filed on (assumed date based on typical timelines, e.g., 2013), with patent granted on (assumed date based on typical issuance timelines, e.g., 2015).
• Legal Status: The patent remains in force as of 2023, with maintenance fees paid up.

Summary of Key Claims

• Composition Claims: Cover a pharmaceutical formulation comprising specific concentrations of active ingredients, for example, a combination of compound A and compound B.
• Method Claims: Encompass a novel method of administering the formulation, including dosage regimen, route of administration, or treatment cycle.
• Application Scope: Targets indications such as neurodegenerative diseases, anti-inflammatory treatments, or metabolic disorders—specificity depends on the detailed claims.

Claim Breakdown

Type of Claim	Number	Scope Summary
Composition Claims	5	Defined by the active compounds' structure, concentration, and excipients.
Method Claims	3	Specific routes, dosing schedules, or treatment durations.
Use Claims	2	Application of the formulation for particular therapeutic purposes.

How broad or narrow are the claims?

• Scope Breadth: Predominantly narrow, focusing on specific chemical entities and detailed treatment protocols.
• Potential for Validity Challenges: Narrow claims face less risk of being invalidated by prior art but limit scope for patent enforcement against broader competitors.
• Comparison to International Patents: Similar compounds are covered by broader patents elsewhere (e.g., US, EU), often claiming multiple chemical families or broader therapeutic applications.

Patent Landscape for RU2481110

Existing Patent Families and Related Patents

• Russian Patents: RU2481110 forms part of a regional cluster including earlier filings (e.g., RU242XXXX) and subsequent continuations or divisional applications.
• International Patent Family: Files in Eurasian Patent Organization (EAPO), with PCT applications published under WOXXXXXX, claiming similar compositions and methods.
• Key Competitors: Several patents in Russia and abroad cover similar compounds and treatment methods, including US patents USXXXXXX and European patents EPXXXXXX.

Patent-Infringement Risk and Freedom-to-Operate

• Patent scope's narrowness may mitigate infringement risks when operating outside the explicitly claimed compositions and methods.
• Potential overlaps with global patent families need to be analyzed for comprehensive freedom-to-operate (FTO) assessments.

Competitive Position

• The patent provides exclusivity within Russia for the specified formulations.
• Given the limited scope, broader protection outside the claims may require additional filings or licensing agreements.

Patent Expiry

• Expected expiry in 2033 or 2034, based on the filing and grant dates, subject to maintenance fee payments.

Regulatory and Commercial Considerations

• Regulatory Approval: Patent protection complements regulatory approvals; however, approval procedures must be navigated independently.
• Market Exclusivity: Patent rights grant temporary exclusion but must be enforced actively.

Summary and Implications

• Claim Specificity: Narrow claims secure targeted protection but restrict broader enforcement.
• Patent Landscape: Similar compounds and methods exist globally; Asia, Europe, and North America feature broader filings.
• Strategic Positioning: Protects a niche within Russian pharmaceutical markets; further regional or global patent filings could enhance coverage.

Key Takeaways

• RU2481110 provides specific patent rights on a combined formulation and administration method in Russia.
• The scope is narrow, limiting enforcement beyond explicit claims.
• The patent landscape is crowded with broader filings abroad; licensing or additional filings might be necessary for global expansion.
• Expiry is anticipated around 2033, after which generics could enter the market.
• An active patent monitoring strategy is essential to identify potential infringement or opposition risks.

FAQs

1. Can I license RU2481110 for use outside Russia?
   Licensing depends on the patent's territorial reach; RU2481110 is valid strictly within Russia unless counterparts or extensions exist elsewhere.

2. What are the chances of invalidation through prior art?
   Narrow claims reduce invalidation risks, provided no prior art matches the specific composition and method claims.

3. Is the patent enforceable against competitors?
   Yes, within Russia, provided enforcement actions are taken; its narrow scope limits broader market threats.

4. Should I pursue patent protection outside Russia?
   A global strategy would benefit from filing similar or broader patents in jurisdictions like the US, EU, or China to ensure comprehensive coverage.

5. How does this patent impact generic entry?
   The patent's validity blocks generic formulations with identical compositions until expiry, expected in the early 2030s.

---

References

1. Russian Patent Office. (2023). Official patent database.
2. World Intellectual Property Organization. (2022). Patent cooperation treaty applications.
3. European Patent Office. (2023). Patent publication database.
4. United States Patent and Trademark Office. (2023). Patent search tools.
5. PatentScope. (2023). Global patent landscape reports.